• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对神经炎症的帕金森病的病理机制特征分析及潜在治疗药物的鉴定。

Pathomechanism Characterization and Potential Therapeutics Identification for Parkinson's Disease Targeting Neuroinflammation.

机构信息

Department of Neurology, Chang-Gung Memorial Hospital, Chang-Gung University College of Medicine, Taoyuan 33302, Taiwan.

Department of Life Science, National Taiwan Normal University, Taipei 11677, Taiwan.

出版信息

Int J Mol Sci. 2021 Jan 21;22(3):1062. doi: 10.3390/ijms22031062.

DOI:10.3390/ijms22031062
PMID:33494411
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7865530/
Abstract

Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the loss of dopaminergic (DAergic) neurons and the presence of α-synuclein-containing Lewy bodies. The unstructured α-synuclein forms insoluble fibrils and aggregates that result in increased reactive oxygen species (ROS) and cellular toxicity in PD. Neuroinflammation engaged by microglia actively contributes to the pathogenesis of PD. In this study, we showed that VB-037 (a quinoline compound), glycyrrhetic acid (a pentacyclic triterpenoid), inflata ( inflata, a Chinese herbal medicine), and Shaoyao Gancao Tang (SG-Tang, a formulated Chinese medicine) suppressed the nitric oxide (NO) production and interleukin (IL)-1β maturation in α-synuclein-stimulated BV-2 cells. Mouse inflammation antibody array further revealed increased IL-1α, IL-1β, tumor necrosis factor (TNF)-α, interferon (IFN)-γ, IL-6, granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) expression in α-synuclein-inflamed BV-2 cells and compound pretreatment effectively reduced the expression and release of these pro-inflammatory mediators. The test compounds and herbal medicines further reduced α-synuclein aggregation and associated oxidative stress, and protected cells against α-synuclein-induced neurotoxicity by downregulating NLR family pyrin domain containing 1 (NLRP1) and 3 (NLRP3), caspase 1, IL-1β, IL-6, and associated nuclear factor (NF)-κB inhibitor alpha (IκBα)/NF-κB P65 subunit (P65), c-Jun N-terminal kinase (JNK)/proto-oncogene c-Jun (JUN), mitogen-activated protein kinase 14 (P38)/signal transducer and activator of transcription 1 (STAT1) and Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) pathways in dopaminergic neurons derived from α-synuclein-expressing SH-SY5Y cells. Our findings indicate the potential of VB-037, glycyrrhetic acid, inflata, and SG-Tang through mitigating α-synuclein-stimulated neuroinflammation in PD, as new drug candidates for PD treatment.

摘要

帕金森病(PD)是一种常见的神经退行性疾病,其特征是多巴胺能(DAergic)神经元丧失和含有α-突触核蛋白的路易体的存在。无结构的α-突触核蛋白形成不溶性纤维和聚集体,导致 PD 中活性氧(ROS)和细胞毒性增加。小胶质细胞激活的神经炎症积极促进 PD 的发病机制。在这项研究中,我们表明 VB-037(一种喹啉化合物)、甘草酸(一种五环三萜)、inflata(inflata,一种中药)和芍药甘草汤(SG-Tang,一种配方中药)抑制了α-突触核蛋白刺激的 BV-2 细胞中一氧化氮(NO)的产生和白细胞介素(IL)-1β的成熟。小鼠炎症抗体阵列进一步显示,在α-突触核蛋白激活的 BV-2 细胞中,白细胞介素(IL)-1α、IL-1β、肿瘤坏死因子(TNF)-α、干扰素(IFN)-γ、IL-6、粒细胞-巨噬细胞集落刺激因子(GM-CSF)和粒细胞集落刺激因子(G-CSF)的表达增加,而化合物预处理有效降低了这些促炎介质的表达和释放。测试化合物和草药进一步减少了α-突触核蛋白的聚集和相关的氧化应激,并通过下调 NOD 样受体家族含pyrin 域蛋白 1(NLRP1)和 3(NLRP3)、半胱天冬酶 1、白细胞介素(IL)-1β、白细胞介素(IL)-6 和相关核因子(NF)-κB 抑制剂α(IκBα)/NF-κB P65 亚基(P65)、c-Jun N 末端激酶(JNK)/原癌基因 c-Jun(JUN)、丝裂原活化蛋白激酶 14(P38)/信号转导和转录激活因子 1(STAT1)和 Janus 激酶 2(JAK2)/信号转导和转录激活因子 3(STAT3)途径,来保护多巴胺能神经元免受源自α-突触核蛋白表达的 SH-SY5Y 细胞的神经毒性。我们的研究结果表明,VB-037、甘草酸、inflata 和 SG-Tang 通过减轻 PD 中α-突触核蛋白刺激的神经炎症,具有成为 PD 治疗新药物候选物的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a0/7865530/2f44d184d951/ijms-22-01062-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a0/7865530/076606cdbaa3/ijms-22-01062-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a0/7865530/c4e4de64d65f/ijms-22-01062-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a0/7865530/cc21bd9e3106/ijms-22-01062-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a0/7865530/7fb79e2f9b92/ijms-22-01062-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a0/7865530/fd6f2421368f/ijms-22-01062-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a0/7865530/a997253d71b9/ijms-22-01062-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a0/7865530/7464abf7cb64/ijms-22-01062-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a0/7865530/2f44d184d951/ijms-22-01062-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a0/7865530/076606cdbaa3/ijms-22-01062-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a0/7865530/c4e4de64d65f/ijms-22-01062-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a0/7865530/cc21bd9e3106/ijms-22-01062-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a0/7865530/7fb79e2f9b92/ijms-22-01062-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a0/7865530/fd6f2421368f/ijms-22-01062-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a0/7865530/a997253d71b9/ijms-22-01062-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a0/7865530/7464abf7cb64/ijms-22-01062-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a0/7865530/2f44d184d951/ijms-22-01062-g008.jpg

相似文献

1
Pathomechanism Characterization and Potential Therapeutics Identification for Parkinson's Disease Targeting Neuroinflammation.针对神经炎症的帕金森病的病理机制特征分析及潜在治疗药物的鉴定。
Int J Mol Sci. 2021 Jan 21;22(3):1062. doi: 10.3390/ijms22031062.
2
Coumarin-chalcone hybrid LM-021 and indole derivative NC009-1 targeting inflammation and oxidative stress to protect BE(2)-M17 cells against α-synuclein toxicity.香豆素-查尔酮杂合体 LM-021 和吲哚衍生物 NC009-1 靶向炎症和氧化应激,以保护 BE(2)-M17 细胞免受α-突触核蛋白毒性的影响。
Aging (Albany NY). 2023 Aug 11;15(16):8061-8089. doi: 10.18632/aging.204954.
3
Investigating the therapeutic effects of novel compounds targeting inflammatory IL-1β and IL-6 signaling pathways in spinocerebellar ataxia type 3.研究靶向脊髓小脑共济失调 3 型炎症性白细胞介素-1β和白细胞介素-6 信号通路的新型化合物的治疗效果。
Eur J Pharmacol. 2024 Mar 15;967:176370. doi: 10.1016/j.ejphar.2024.176370. Epub 2024 Feb 5.
4
Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease.靶向帕金森病中微胶质细胞α-突触核蛋白/TLRs/NF-κB/NLRP3 炎性小体轴
Front Immunol. 2021 Oct 8;12:719807. doi: 10.3389/fimmu.2021.719807. eCollection 2021.
5
Sesquiterpene dimer (DSF-52) from Artemisia argyi inhibits microglia-mediated neuroinflammation via suppression of NF-κB, JNK/p38 MAPKs and Jak2/Stat3 signaling pathways.来自艾蒿的倍半萜二聚体(DSF - 52)通过抑制NF-κB、JNK/p38丝裂原活化蛋白激酶和Jak2/Stat3信号通路来抑制小胶质细胞介导的神经炎症。
Phytomedicine. 2014 Feb 15;21(3):298-306. doi: 10.1016/j.phymed.2013.08.016. Epub 2013 Sep 20.
6
Pathomechanism characterization and potential therapeutics identification for SCA3 targeting neuroinflammation.针对神经炎症的 SCA3 的病理机制特征描述和潜在治疗方法的鉴定。
Aging (Albany NY). 2020 Nov 10;12(23):23619-23646. doi: 10.18632/aging.103700.
7
Formulated Chinese medicine Shaoyao Gancao Tang reduces NLRP1 and NLRP3 in Alzheimer's disease cell and mouse models for neuroprotection and cognitive improvement.中药芍药甘草汤通过减少阿尔茨海默病细胞和小鼠模型中的 NLRP1 和 NLRP3 实现神经保护和认知改善。
Aging (Albany NY). 2021 Jun 9;13(11):15620-15637. doi: 10.18632/aging.203125.
8
Formulated Chinese Medicine Shaoyao Gancao Tang Reduces Tau Aggregation and Exerts Neuroprotection through Anti-Oxidation and Anti-Inflammation.复方中药芍药甘草汤通过抗氧化和抗炎作用减少 Tau 聚集并发挥神经保护作用。
Oxid Med Cell Longev. 2018 Oct 28;2018:9595741. doi: 10.1155/2018/9595741. eCollection 2018.
9
Neuroinflammation in Parkinson's Disease and its Treatment Opportunities.帕金森病中的神经炎症及其治疗机会。
Balkan Med J. 2022 Sep 9;39(5):318-333. doi: 10.4274/balkanmedj.galenos.2022.2022-7-100. Epub 2022 Aug 29.
10
Ilex asprella aqueous extracts exert in vivo anti-inflammatory effects by regulating the NF-κB, JAK2/STAT3, and MAPK signaling pathways.苦丁茶水提物通过调控 NF-κB、JAK2/STAT3 和 MAPK 信号通路发挥体内抗炎作用。
J Ethnopharmacol. 2018 Oct 28;225:234-243. doi: 10.1016/j.jep.2018.06.037. Epub 2018 Jul 4.

引用本文的文献

1
Oxidative stress and dysregulated long noncoding RNAs in the pathogenesis of Parkinson's disease.氧化应激与长链非编码RNA失调在帕金森病发病机制中的作用
Biol Res. 2025 Jan 27;58(1):7. doi: 10.1186/s40659-025-00585-7.
2
Coumarin-chalcone derivatives as dual NLRP1 and NLRP3 inflammasome inhibitors targeting oxidative stress and inflammation in neurotoxin-induced HMC3 and BE(2)-M17 cell models of Parkinson's disease.香豆素-查尔酮衍生物作为双重NLRP1和NLRP3炎性小体抑制剂,在神经毒素诱导的帕金森病HMC3和BE(2)-M17细胞模型中靶向氧化应激和炎症
Front Aging Neurosci. 2024 Oct 1;16:1437138. doi: 10.3389/fnagi.2024.1437138. eCollection 2024.
3

本文引用的文献

1
Bisdemethoxycurcumin exerts a cell-protective effect via JAK2/STAT3 signaling in a rotenone-induced Parkinson's disease model in vitro.双去甲氧基姜黄素通过 JAK2/STAT3 信号通路在鱼藤酮诱导的帕金森病体外模型中发挥细胞保护作用。
Folia Histochem Cytobiol. 2020;58(2):127-134. doi: 10.5603/FHC.a2020.0011. Epub 2020 Jun 18.
2
Polyphenols from Toona sinensiss Seeds Alleviate Neuroinflammation Induced by 6-Hydroxydopamine Through Suppressing p38 MAPK Signaling Pathway in a Rat Model of Parkinson's Disease.香椿籽油多酚通过抑制 p38 MAPK 信号通路缓解帕金森病大鼠模型中 6-羟多巴胺诱导的神经炎症。
Neurochem Res. 2020 Sep;45(9):2052-2064. doi: 10.1007/s11064-020-03067-2. Epub 2020 Jun 17.
3
Differentiation and regulation of CD4 T cell subsets in Parkinson's disease.
帕金森病中 CD4 T 细胞亚群的分化与调控。
Cell Mol Life Sci. 2024 Aug 17;81(1):352. doi: 10.1007/s00018-024-05402-0.
4
From inflammatory signaling to neuronal damage: Exploring NLR inflammasomes in ageing neurological disorders.从炎症信号传导到神经元损伤:探索衰老神经疾病中的NLR炎性小体
Heliyon. 2024 Jun 11;10(12):e32688. doi: 10.1016/j.heliyon.2024.e32688. eCollection 2024 Jun 30.
5
The Interaction Between Nutraceuticals and Gut Microbiota: a Novel Therapeutic Approach to Prevent and Treatment Parkinson's Disease.营养保健品与肠道微生物群的相互作用:预防和治疗帕金森病的新治疗方法。
Mol Neurobiol. 2024 Nov;61(11):9078-9109. doi: 10.1007/s12035-024-04151-2. Epub 2024 Apr 8.
6
Inflammasomes in neurological disorders - mechanisms and therapeutic potential.神经紊乱中的炎性小体——作用机制与治疗潜能。
Nat Rev Neurol. 2024 Feb;20(2):67-83. doi: 10.1038/s41582-023-00915-x. Epub 2024 Jan 9.
7
NEAT1 enhances MPP -induced pyroptosis in a cell model of Parkinson's disease via targeting miR-5047/YAF2 signaling.NEAT1 通过靶向 miR-5047/YAF2 信号增强 MPP+诱导的帕金森病细胞模型中的细胞焦亡。
Immun Inflamm Dis. 2023 Jun;11(6):e817. doi: 10.1002/iid3.817.
8
Characterization of Inflammatory Signals in BV-2 Microglia in Response to Wnt3a.BV-2小胶质细胞中响应Wnt3a的炎症信号特征
Biomedicines. 2023 Apr 7;11(4):1121. doi: 10.3390/biomedicines11041121.
9
Using ΔK280 Tau Folding Reporter Cells to Screen TRKB Agonists as Alzheimer's Disease Treatment Strategy.使用 ΔK280Tau 折叠报告细胞筛选作为阿尔茨海默病治疗策略的 TRKB 激动剂。
Biomolecules. 2023 Jan 23;13(2):219. doi: 10.3390/biom13020219.
10
The Interplay between α-Synuclein and Microglia in α-Synucleinopathies.α-突触核蛋白与小胶质细胞在 α-突触核蛋白病中的相互作用。
Int J Mol Sci. 2023 Jan 27;24(3):2477. doi: 10.3390/ijms24032477.
Lactulose and Melibiose Inhibit α-Synuclein Aggregation and Up-Regulate Autophagy to Reduce Neuronal Vulnerability.
乳果糖和棉子糖通过抑制α-突触核蛋白聚集和上调自噬来减少神经元易损性。
Cells. 2020 May 16;9(5):1230. doi: 10.3390/cells9051230.
4
Neuroprotective Effect of AM404 Against NMDA-Induced Hippocampal Excitotoxicity.AM404对N-甲基-D-天冬氨酸诱导的海马兴奋性毒性的神经保护作用。
Front Cell Neurosci. 2019 Dec 20;13:566. doi: 10.3389/fncel.2019.00566. eCollection 2019.
5
NF-κB-Mediated Neuroinflammation in Parkinson's Disease and Potential Therapeutic Effect of Polyphenols.NF-κB 介导的帕金森病神经炎症及多酚的潜在治疗作用。
Neurotox Res. 2020 Mar;37(3):491-507. doi: 10.1007/s12640-019-00147-2. Epub 2019 Dec 10.
6
miR-let-7a suppresses α-Synuclein-induced microglia inflammation through targeting STAT3 in Parkinson's disease.miR-let-7a 通过靶向 STAT3 抑制帕金森病中 α-Synuclein 诱导的小胶质细胞炎症。
Biochem Biophys Res Commun. 2019 Nov 19;519(4):740-746. doi: 10.1016/j.bbrc.2019.08.140. Epub 2019 Sep 20.
7
Plasma IL-6 and IL-17A Correlate with Severity of Motor and Non-Motor Symptoms in Parkinson's Disease.血浆 IL-6 和 IL-17A 与帕金森病运动和非运动症状的严重程度相关。
J Parkinsons Dis. 2019;9(4):705-709. doi: 10.3233/JPD-191699.
8
The Role of Neuronal NLRP1 Inflammasome in Alzheimer's Disease: Bringing Neurons into the Neuroinflammation Game.神经元 NLRP1 炎性小体在阿尔茨海默病中的作用:将神经元纳入神经炎症游戏。
Mol Neurobiol. 2019 Nov;56(11):7741-7753. doi: 10.1007/s12035-019-1638-7. Epub 2019 May 20.
9
Fyn kinase regulates misfolded α-synuclein uptake and NLRP3 inflammasome activation in microglia.Fyn 激酶调节微胶质细胞中错误折叠的 α-突触核蛋白摄取和 NLRP3 炎性小体的激活。
J Exp Med. 2019 Jun 3;216(6):1411-1430. doi: 10.1084/jem.20182191. Epub 2019 Apr 29.
10
Inflammasomes in neuroinflammatory and neurodegenerative diseases.炎症小体与神经炎症和神经退行性疾病。
EMBO Mol Med. 2019 Jun;11(6). doi: 10.15252/emmm.201810248.